Gentle electrical brain stimulation (anodal tDCS) to help arm recovery after stroke
Official title: Use of Anodal Transcranial Direct Current Stimulation to Enhance Upper Limb Recovery in Stroke
Run by Tan Tock Seng Hospital · NCT07151729 · Data updated 2026-11-12
This trial will test whether anodal transcranial direct current stimulation (tDCS) applied to the unaffected side of the brain helps people with recent severe arm weakness after stroke recover better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 80 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Tan Tock Seng Hospital Academic / other |
| Locations | 1 site (Singapore, Singapore) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | September 15, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 3, 2025 |
| Trial ID | NCT07151729 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 21–80 with a first unilateral ischaemic or haemorrhagic stroke within 8 weeks and severe weakness of one upper limb (SAFE score <5) who can provide informed consent or have a legal guardian are eligible.
✕Probably not a fit
Patients with bilateral or cerebellar strokes, prior seizures, significant brain surgery or implants, severe cognitive impairment, or pre-existing arm pathology are excluded and unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, blinded, sham-controlled trial using the Soterix Medical 1x1 tDCS stimulator to deliver either real or sham anodal stimulation to the unaffected hemisphere. Fifty hospitalized patients with subacute unilateral stroke and severe upper limb weakness (within 8 weeks of onset, SAFE score <5) will be randomized 1:1 to active or sham tDCS. The team will measure clinical efficacy, technical feasibility, and safety of the intervention during inpatient rehabilitation. The trial is conducted at Tan Tock Seng Hospital Integrated Care Hub with standard rehabilitation care provided to all participants.
Why it matters
Potential benefit: If successful, this approach could speed or improve recovery of arm movement in people with severe weakness after subacute stroke.
How similar studies have gone: Anodal tDCS has been used in multiple randomized trials in stroke rehabilitation and has shown promising but mixed benefits in improving motor recovery.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * First ever unilateral ischaemic or haemorrhagic stroke, as documented by CT or MRI scans * Age 21-80 years, both males and females * Within 8 weeks of stroke onset * Severe weakness of one upper limb, defined by a Shoulder Abduction and Finger Extension (SAFE) score \< 5 (Medical Research Council grading) * Provision of informed consent by patient or a legal guardian in accordance with the local ethics committee guidelines and the Declaration of Helsinki Exclusion Criteria: * Bilateral hemispheric or cerebellar strokes * Pre-existing arm pathology (e.g. contracture, severe pain, etc.) on the affected side * Presence of brain implants, and previous insertion of external ventricular drains. * Metallic implants at the level of the neck, mouth cavity and below are permitted (e.g. Cardiac stents, dental implants, pacemakers and other metallic objects) * A history of spontaneous seizures, epilepsy, brain tumour, and cranial surgery * Severe cognitive impairment (MOCA Score \<10) that would hinder sufficient understanding of the instructions * Pregnancy
Where it's running
-
Tan Tock Seng Hospital - Integrated Care Hub
Singapore, Singapore, Singapore Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.